Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
36
HALB Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
158.99%
Day range:
$0.0014 - $0.0016
52-week range:
$0.0011 - $0.0045
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
87.8K
Avg. volume:
1.5M
1-year change:
-54.69%
Market cap:
$922K
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Halberd Corp. has -- downside to fair value with a price target of -- per share.
HALB vs. S&P 500
-
Over the past 5 trading days, Halberd Corp. has overperformed the S&P 500 by 14.37% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Halberd Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Halberd Corp. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Halberd Corp. reported revenues of --.
Earnings Growth
-
Halberd Corp. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Halberd Corp. reported earnings per share of --.
Enterprise value:
1.1M
EV / Invested capital:
-1.53x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-238.45x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$500
Return On Assets:
-405.26%
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | $2K | $800 | -- | -- | -- | |
| Gross Profit | -$100 | -$200 | -$500 | -$200 | -$200 | |
| Operating Income | -$261.9K | -$34.1K | -$20.3K | -$7.5K | -$9.2K | |
| EBITDA | -$260.8K | -$33.4K | -$19.8K | -$7.4K | -$9K | |
| Diluted EPS | -$0.00 | -- | -- | -- | -- | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29.2K | $9.1K | $8.7K | $6.3K | $1.8K | |
| Total Assets | $30.5K | $13.4K | $12K | $9.1K | $4.3K | |
| Current Liabilities | $317.6K | $743.7K | $760K | $759.7K | $704K | |
| Total Liabilities | $453.1K | $893.7K | $910K | $909.7K | $854K | |
| Total Equity | -$422.7K | -$880.3K | -$898K | -$900.6K | -$849.7K | |
| Total Debt | $135.6K | $150K | $150K | $150K | $150K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$201.7K | -$12.6K | -$4.4K | -$9K | -$6.5K | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | $205.6K | $6.5K | -- | $6.5K | $6.5K | |
| Free Cash Flow | -$201.7K | -$12.6K | -$4.5K | -$9K | -$6.5K | |
HALB
Sector
Market Cap
$922K
--
Price % of 52-Week High
32.22%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-54.69%
--
Beta (5-Year)
0.342
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.0013
200-day SMA
Sell
Level
$0.0021
Bollinger Bands (100)
Sell
Level
0.0019 - 0.0019
Chaikin Money Flow
Buy
Level
3.1M
20-day SMA
Buy
Level
$0.0014
Relative Strength Index (RSI14)
Buy
Level
50.7447
ADX Line
Buy
Level
10.0047
Williams %R
Neutral
Level
-30
50-day SMA
Sell
Level
$0.0016
MACD (12, 26)
Buy
Level
0.0002
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
106.8K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2394.2496)
Sell
CA Score
(Annual)
Level (-515.5173)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1515.1277)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Halberd Corp. is a development stage company, which engages in the research and development of antibodies and devices for the prevention, detection, and treatment of neurodegenerative diseases. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer's Disease, and Parkinson's Disease. The company was founded by Mark Sven Lundquist and John Christopher Maddox on January 26, 2009 and is headquartered in Jackson Center, PA.
Stock Forecast FAQ
In the current month, HALB has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HALB average analyst price target in the past 3 months is --.
-
Where Will Halberd Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Halberd Corp. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Halberd Corp.?
Analysts are divided on their view about Halberd Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Halberd Corp. is a Sell and believe this share price will rise from its current level to --.
-
What Is Halberd Corp.'s Price Target?
The price target for Halberd Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HALB A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Halberd Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HALB?
You can purchase shares of Halberd Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Halberd Corp. shares.
-
What Is The Halberd Corp. Share Price Today?
Halberd Corp. was last trading at $0.0000 per share. This represents the most recent stock quote for Halberd Corp.. Yesterday, Halberd Corp. closed at $0.0015 per share.
-
How To Buy Halberd Corp. Stock Online?
In order to purchase Halberd Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HALB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HALB
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
HALB
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
HALB
Sector
Profitability FY 2025
-$500
--
Return on invested capital
--
--
Return on assets
-405.26%
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
25
Next Earnings Date
Dec
25
Estimated Next Earnings Date
Mar
26
Balance Sheet
HALB
Sector
Total cash
--
--
Short term investments
--
--
Total assets
$4.5K
--
Long term debt
$150K
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
